CMS Innovation Center Tapped To Consider Models Targeting Prescription Drug Spending

By Gabrielle Wanneh / September 13, 2021 at 12:16 PM
HHS’ drug price control plan calls for CMS demonstrations that target rebates and pharmacy price concessions and that enlist doctors to control total cost of care. CMS’ innovation center could run small-scale mandatory models in Part B that link drug payment to patient outcomes and health disparities. HHS suggests CMS test a policy of rewarding doctors who choose high-value, less-expensive therapies by sharing Part B savings from generics and biosimilars with them. Employer-sponsored plans also could participate. The demo also...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.